Authors: Antoniu, Sabina Antonela; Monica Pop, Carmen

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 5, April 2009 , pp. 917-919(3)

Publisher: Informa Healthcare

Abstract:

Background: In asthma small airways inflammation often persists despite inhaled corticosteroids therapy. Objective: To discuss the effects of ciclesonide, a newer inhaled corticosteroid on small airways inflammation and the reliability of some biomarkers of small airways inflammation in asthma. Methods and results: Evaluation of a study assessing the short-term effects of ciclesonide on small airways inflammation in patients with mild to moderate asthma. Conclusions: Ciclesonide could have beneficial effects on small airways inflammation and some of the outcome measures used as efficacy endpoints could represent possible biomarkers of small airways involvement in obstructive chronic respiratory diseases.

Keywords: small airways-inflammation-asthma-ciclesonide

Document Type: Research article

DOI: http://dx.doi.org/10.1517/14656560902824160

Publication date: 2009-04-01

More about this publication?

• Editorial Board
• Information for Authors
• Subscribe to this Title
• Terms & Conditions
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Antoniu, Sabina Antonela ;  Monica Pop, Carmen

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers